Handbook of Clinical medicine
KEYWORDS: patient, disease, patients, history, pain, heart, symptoms, ask, time, treatment, risk, examination, aortic, iinnddbb, pulse

one brand (bioavailability varies). __OOHHCCMM__1100ee..iinnddbb 881100 0022//0055//22001177 1199::0099 seicnegremE  Management of acute asthma 811 Assess severity of attack: PEF, ability to speak, RR, pulse rate, O2 sats Warn ICU if severe or life-threatening attack Immediate treatment: Supplemental O2 to maintain sats 94–98% Salbutamol 5mg (or terbutaline 10mg) nebulized with O2 If severe/life-threatening add in ipratropium 0.5mg/6h to nebulizers Hydrocortisone 100mg IV or prednisolone 40–50mg PO Reassess every 15min: • If PEF <75% repeat salbutamol nebulizers every 15–30min, or 10mg/h continuously. Add ipratropium if not already given • Monitor ECG; watch for arrhythmias • Consider single dose of magnesium sulfate (MgSO4) 1 . 2–2g IV over 20min in those with severe/life-threatening features without good initial response to therapy If not improving: If improving within 15–30min: Refer to ICU for consideration of • Continue nebulized salbutamol ventilatory support and intensifi - every 4–6h (+ ipratropium if cation of medical therapy, eg ami- started in previous step) nophylline, IV salbutamol if any of • Prednisolone 40–50mg PO OD the following signs are present: for 5–7 days • Deteriorating PEF • Monitor peak fl ow and O2 • Persistent/worsening hypoxia sats, aim 94–98% with sup- • Hypercapnia plemental if needed • ABG showing
